Moore Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-100,000
| Closed | -$5M | – | 486 |
|
|
2023
Q1 | $5M | Buy |
+100,000
| New | +$5M | 0.11% | 137 |
|
|
2022
Q4 | – | Sell |
-479,888
| Closed | -$18.6M | – | 546 |
|
|
2022
Q3 | $18.6M | Buy |
+479,888
| New | +$18.6M | 0.44% | 35 |
|
|
2022
Q2 | – | Sell |
-358,472
| Closed | -$15.9M | – | 684 |
|
|
2022
Q1 | $15.9M | Buy |
358,472
+14,330
| +4% | +$635K | 0.4% | 34 |
|
|
2021
Q4 | $14.6M | Buy |
+344,142
| New | +$14.6M | 0.29% | 62 |
|
|
2021
Q2 | – | Sell |
-556,409
| Closed | -$21.5M | – | 796 |
|
|
2021
Q1 | $21.5M | Buy |
556,409
+47,775
| +9% | +$1.85M | 0.27% | 59 |
|
|
2020
Q4 | $18.3M | Buy |
508,634
+179,632
| +55% | +$6.46M | 0.2% | 59 |
|
|
2020
Q3 | $12.6M | Buy |
329,002
+179,002
| +119% | +$6.84M | 0.24% | 77 |
|
|
2020
Q2 | $5.27M | Buy |
+150,000
| New | +$5.27M | 0.14% | 124 |
|